| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/17/2009 | US20090311250 Methods and compositions for the diagnosis and treatment of cancer |
| 12/17/2009 | US20090311249 Capecitabine Combination Therapy |
| 12/17/2009 | US20090311248 Hepatitis C Virus Neutralizing Antibodies |
| 12/17/2009 | US20090311247 Molecules and chimeric molecules thereof |
| 12/17/2009 | US20090311246 Method of Enhancing Remyelination in Demyelinating Diseases of the Central Nervous System |
| 12/17/2009 | US20090311245 Metalloproteinase 9 binding proteins |
| 12/17/2009 | US20090311244 Screening Method |
| 12/17/2009 | US20090311243 Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis |
| 12/17/2009 | US20090311242 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 12/17/2009 | US20090311241 Human antibodies that bind human IL-12 and methods for producing |
| 12/17/2009 | US20090311229 Isolation and Identification of Cross-Reactive T Cells |
| 12/17/2009 | US20090311217 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 12/17/2009 | US20090311183 Metalloproteinase 12 binding proteins |
| 12/17/2009 | US20090311181 Engineered Anti-Prostate Stem Cell Antigen (PSCA) Antibodies for Cancer Targeting |
| 12/17/2009 | US20090311180 Protein Isoforms and Uses Thereof |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | CA2727866A1 Novel peptide adjuvant for influenza vaccination |
| 12/17/2009 | CA2727852A1 Treatment of chronic prostatitis |
| 12/17/2009 | CA2727811A1 Conjugates for the administration of biologically active compounds |
| 12/17/2009 | CA2727485A1 Iqgap3 epitope peptides and vaccines containing the same |
| 12/17/2009 | CA2727322A1 Combined influenza vaccines for seasonal and pandemic protection |
| 12/17/2009 | CA2727141A1 Compositions and methods for modulating nicotinic/nmda receptor function |
| 12/17/2009 | CA2727086A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
| 12/17/2009 | CA2720365A1 Bcr-complex-specific antibodies and methods of using same |
| 12/16/2009 | WO2009154651A1 Treatment of metastic breast cancer by a combination of two anti-her2 antibodies and a taxene |
| 12/16/2009 | EP2133428A1 New baculovirus vectors for improved protein production |
| 12/16/2009 | EP2133365A2 Compositions and methods for the treatment of infections and tumors |
| 12/16/2009 | EP2133362A1 Antagonists and agonists of LDCAM and methods of use |
| 12/16/2009 | EP2133359A2 Recombinant haemophilus influenzae adhesin proteins |
| 12/16/2009 | EP2133358A1 Rift valley fever virus-like particles and their use for immunization and as test system |
| 12/16/2009 | EP2133100A1 MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof |
| 12/16/2009 | EP2133095A1 Pharmaceutical composition |
| 12/16/2009 | EP2133094A1 Pharmaceutical composition |
| 12/16/2009 | EP2133093A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 12/16/2009 | EP2133092A1 Oral vaccine |
| 12/16/2009 | EP2132573A2 Predicting response to a her dimerisation inhbitor based on low her3 expression |
| 12/16/2009 | EP2132228A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 12/16/2009 | EP2132226A2 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1) |
| 12/16/2009 | EP2131863A1 A method of treating malignant mesothelioma |
| 12/16/2009 | EP2131860A2 Anti-sclerostin antibodies |
| 12/16/2009 | EP2131857A2 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/16/2009 | EP2131856A2 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 12/16/2009 | EP1996229B1 Intranasal influenza vaccine based on virosomes |
| 12/16/2009 | EP1879998B1 Leptospirosis culture process |
| 12/16/2009 | EP1521832B1 Anti-fragilis antibody and uses thereof |
| 12/16/2009 | EP1434603B1 Method of treatment using ligand-immunogen conjugates |
| 12/16/2009 | EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 12/16/2009 | EP1407023B1 Group b streptococcus antigens and corresponding dna fragments |
| 12/16/2009 | EP1114189B1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 12/16/2009 | EP0996455B1 Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof |
| 12/16/2009 | CN101606062A Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 12/16/2009 | CN101605815A Method and arrangement for allowing enterprise and personal domains in the ims |
| 12/16/2009 | CN101605814A Engineered anti-TSLP antibody |
| 12/16/2009 | CN101605811A Treatment of cachexia |
| 12/16/2009 | CN101605808A Recombinant antigens of human cytomegalovirus (HCMV) |
| 12/16/2009 | CN101605561A Treatment of diabetes by at least one epidermal growth factor receptor specific antibody or a derivative thereof |
| 12/16/2009 | CN101605560A A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |
| 12/16/2009 | CN101605559A Treatment of immune disease by mucosal delivery of antigens |
| 12/16/2009 | CN101605558A Influenza recombinant subunit vaccine |
| 12/16/2009 | CN101605547A Methods of treating chronic inflammatory diseases using a GM-CSF antagonist |
| 12/16/2009 | CN101605532A Protein formulations containing sorbitol |
| 12/16/2009 | CN101603035A Porcine reproductive and respiratory syndrome virus chimeric recombinant vaccine strain and method for producing living vaccine with same |
| 12/16/2009 | CN101603024A Porcine mycoplasmal pneumonia and porcine infectious actinobacillus pleuropneumoniae serum 1 type gene engineering strain vaccine and application thereof |
| 12/16/2009 | CN101602809A Antibody targeted complement inhibitor with anti-inflammatory action |
| 12/16/2009 | CN101602808A Specific binding protein and application thereof |
| 12/16/2009 | CN101602807A Mammalian cytokines, reagent and method thereof |
| 12/16/2009 | CN101601861A Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 12/16/2009 | CN101601860A Vaccine |
| 12/16/2009 | CN100569287C Immunoglobulin for dog intravenous injection, its preparing method and the formulation thereof |
| 12/16/2009 | CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability |
| 12/16/2009 | CN100569285C Application of immunological stimulant compound in preparing fish immunity preparation |
| 12/16/2009 | CA2671223A1 Treatment of metastatic breast cancer |
| 12/15/2009 | US7632980 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems |
| 12/15/2009 | US7632926 Humanized monoclonal antibodies to hepatocyte growth factor |
| 12/15/2009 | US7632925 Antibodies that bind human 17-A1/EpCAM tumor antigen |
| 12/15/2009 | US7632923 Lymphotropic retrovirus disease treatment and diagnosis such as acquired immunodeficiency syndrome (AIDS); Specifically binds with high specificity and affinity a particular human APM:pathogen-derived antigen complex |
| 12/15/2009 | US7632917 Complex comprising peptide substrate such as synaptosomal associated protein, syntaxin, isoforms, vesicle-associated membrane protein, and motif of soluble NSF (N-ethylmaleimide-sensitive fusion protein) attachment protein receptor, reporter domain comprising red fluorescent protein |
| 12/15/2009 | US7632816 Treatment of Alzheimer amyloid deposition |
| 12/15/2009 | US7632807 Cyclosporin alkynes and their utility as pharmaceutical agents |
| 12/15/2009 | US7632659 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 12/15/2009 | US7632646 Tuberculosis diagnostic test |
| 12/15/2009 | US7632643 PCA3, PCA3 genes, and methods of use |
| 12/15/2009 | US7632528 Simple and effective method for the prophylactic treatment of migraine substantially free of any side effects such as damage/irritation to the nasal mucosa membrane |
| 12/15/2009 | US7632516 Moraxella catarrhalis BASB115 polypeptides |
| 12/15/2009 | US7632515 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 12/15/2009 | US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc |
| 12/15/2009 | US7632513 amino acid sequence of subunit A of a cholera toxin (CT-A) or a fragment of the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment, where in Ser-63 and Arg-192 are replaced with another amino acid |
| 12/15/2009 | US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections |
| 12/15/2009 | US7632511 Yeast-based therapeutic for chronic hepatitis C infection |
| 12/15/2009 | US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence |
| 12/15/2009 | US7632509 Methods to express recombinant proteins from lentiviral vectors |
| 12/15/2009 | US7632508 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 12/15/2009 | US7632507 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders |
| 12/15/2009 | US7632506 Relates to peptides which bind to MHC molecules of either Class I or Class II; the peptides consist of amino acid sequences found in the NY-ESO-1 molecule; useful in treating cancerous conditions |
| 12/15/2009 | US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 12/15/2009 | US7632503 Using human insulin-like growth factor-1 (IGF-1) fusion protein as therapeutic in treatment and prevention of muscular disorders |
| 12/15/2009 | US7632502 Immunoglobulin for diagnosis and prevention of yeast infections |
| 12/15/2009 | US7632501 Antibodies against monocyte chemotactic proteins |
| 12/15/2009 | US7632500 Immunoglobulin for use in prevention and treatment inflammatory disease |
| 12/15/2009 | US7632499 Anti-myostatin antibodies |